IBDEI0UA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14938,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14938,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,14938,1,5,0)
 ;;=5^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,14938,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,14939,0)
 ;;=V13.01^^89^900^25
 ;;^UTILITY(U,$J,358.3,14939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14939,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,14939,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,14939,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,14940,0)
 ;;=302.71^^89^900^36
 ;;^UTILITY(U,$J,358.3,14940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14940,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,14940,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,14940,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,14941,0)
 ;;=596.54^^89^900^38
 ;;^UTILITY(U,$J,358.3,14941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14941,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,14941,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,14941,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,14942,0)
 ;;=788.43^^89^900^39
 ;;^UTILITY(U,$J,358.3,14942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14942,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,14942,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,14942,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,14943,0)
 ;;=605.^^89^900^42
 ;;^UTILITY(U,$J,358.3,14943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14943,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,14943,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,14943,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,14944,0)
 ;;=601.0^^89^900^44
 ;;^UTILITY(U,$J,358.3,14944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14944,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,14944,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,14944,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,14945,0)
 ;;=590.10^^89^900^46
 ;;^UTILITY(U,$J,358.3,14945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14945,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,14945,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,14945,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,14946,0)
 ;;=590.00^^89^900^47
 ;;^UTILITY(U,$J,358.3,14946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14946,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,14946,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,14946,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,14947,0)
 ;;=788.7^^89^900^54
 ;;^UTILITY(U,$J,358.3,14947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14947,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,14947,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,14947,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,14948,0)
 ;;=131.02^^89^900^57
 ;;^UTILITY(U,$J,358.3,14948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14948,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,14948,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,14948,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,14949,0)
 ;;=597.80^^89^900^55
 ;;^UTILITY(U,$J,358.3,14949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14949,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,14949,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,14949,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,14950,0)
 ;;=788.41^^89^900^58
 ;;^UTILITY(U,$J,358.3,14950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14950,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,14950,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,14950,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,14951,0)
 ;;=788.31^^89^900^62
 ;;^UTILITY(U,$J,358.3,14951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14951,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,14951,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,14951,2)
 ;;=^260046
